We are thrilled to announce that Harold “Hal” Collard has accepted the position of Co-Director for the Clinical and Translational Science Institute (CTSI). After an exhaustive review of a large number of highly qualified candidates, the search committee selected Hal based on his unique combination of research, clinical and teaching excellence. We are confident that Hal is the right person to provide leadership for CTSI as we move into the next grant cycle and continue efforts to more tightly integrate with UCSF’s research enterprise.
Hal is associate professor of Clinical Medicine in the Division of Pulmonary, Critical Care, Sleep and Allergy of the Department of Medicine and director of UCSF’s Interstitial Lung Disease (ILD) Program. As head of the UCSF ILD Program, he oversees a consultative clinic that provides multidisciplinary diagnosis and management to over 450 new patients and hundreds of follow-up patients each year.
Interstitial lung disease and pulmonary fibrosis have been Hal’s primary research focus since he joined the faculty at UCSF. He has a number of grants and has published extensively on these topics. His experience running clinical trials and fostering multidisciplinary team science-based approaches is particularly valuable to CTSI as we seek to improve infrastructure in these areas.
In addition to Hal’s research and clinical accomplishments, he is also a dedicated teacher and mentor to junior faculty, fellows, visiting scholars and students. Hal’s experience providing thoughtful guidance and leadership to others will undoubtedly be an asset to our programs and staff.
Hal will be stepping into his new role immediately.
This announcement coincides with the retirement of Deborah Grady, CTSI’s Co-director and one of its founders, who has provided invaluable leadership and research excellence that spans over 35 years since she first began at UCSF as a trainee. Deborah also led CTSI Training programs for many years, and mentored multiple UCSF investigators at all levels. Deborah will continue to work on CTSI initiatives such as eConsent and Online Education, as well as providing advice during the transition. We will sincerely miss her leadership and inspiration.
- Jennifer Grandis, MD
AVC of Clinical and Translational Research and Director of CTSI